ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9515
0.05%
Brent Oil
83.825
0.34%
Bitcoin
57,487.50
-1.29%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. aTyr Pharma Inc (LIFE)

  7. aTyr Pharma Inc (LIFE) Noticias

LIFE aTyr Pharma Inc

1.59
0.02 (1.27%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
aTyr Pharma Inc LIFE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.02 1.27% 1.59 18:50:42
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.56 1.56 1.61 1.59 1.57
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/4/202407:00GLOBEaTyr Pharma to Participate in April Investor Conferences
14/3/202415:00GLOBEaTyr Pharma Announces Fourth Quarter and Full Year 2023..
28/2/202407:00GLOBEaTyr Pharma to Webcast Conference Call Reporting Fourth..
21/2/202407:00GLOBEaTyr Pharma Announces Expanded Access Program (EAP) for..
06/2/202419:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202419:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202407:00GLOBEaTyr Pharma to Present Posters Highlighting Importance of..
18/1/202407:00GLOBEaTyr Pharma Announces Howard University President Emeritus..
09/1/202418:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202418:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202411:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/12/202317:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202307:00GLOBEaTyr Pharma Presents Poster Demonstrating Preclinical..
09/11/202316:01EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202315:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:06EDGAR2Form 8-K - Current report
09/11/202315:00GLOBEaTyr Pharma Announces Third Quarter 2023 Results and..
01/11/202307:00GLOBEaTyr Pharma to Present at November Investor Conferences
31/10/202307:00GLOBEaTyr Pharma Announces Dosing of First Patient in Phase 2..
26/9/202308:01EDGAR2Form 8-K - Current report
11/9/202307:04EDGAR2Form 8-K - Current report
11/9/202307:00GLOBEaTyr Pharma Presents Efzofitimod Data Demonstrating..
24/8/202307:00GLOBEaTyr Pharma to Present at the H.C. Wainwright 25th Annual..
10/8/202315:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:10EDGAR2Form 8-K - Current report
09/8/202315:00GLOBEaTyr Pharma Announces Second Quarter 2023 Results and..
01/8/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/6/202307:00GLOBEEuropean Commission Grants Orphan Drug Designation for aTyr..
20/6/202307:00GLOBEaTyr Pharma to Present on Lead Therapeutic Candidate..
09/6/202315:00GLOBEaTyr Pharma Announces Inducement Grants Under Nasdaq Listing..
06/6/202307:00GLOBEaTyr Pharma to Highlight Advancements in tRNA Synthetase..
25/5/202307:00GLOBEaTyr Pharma to Present at the 2023 Jefferies Healthcare..
22/5/202307:00GLOBEaTyr Pharma Presents New Data on Efzofitimod Mechanism of..
11/5/202315:00GLOBEaTyr Pharma to Present at the 2023 RBC Capital Markets..
09/5/202315:00GLOBEaTyr Pharma Announces First Quarter 2023 Results and..

Su Consulta Reciente

NASDAQ
LIFE
aTyr Pharma
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados